NIAID Names John Powers III as Acting Director
The National Institutes of Health has appointed researcher John Powers III to lead the National Institute of Allergy and Infectious Diseases on an acting basis, according to STAT News. The move ends weeks of questions over who would run the institute, which had been operating without clear leadership.
Powers replaces Jeffery Taubenberger, who had been serving as acting director. NIAID is one of the most prominent institutes within the NIH, funding a large share of federal research on infectious diseases, immunology, and vaccines. The institute was previously led for decades by Anthony Fauci, who retired in 2022.
The appointment matters because NIAID's direction shapes national priorities on pandemic preparedness, vaccine development, and emerging threats. A prolonged leadership vacuum can slow grant decisions and strategic planning. Naming an acting director restores a clear chain of command, though the "acting" label signals that a permanent appointment and longer-term direction remain unsettled.
Sources